Blog Visure Solutions

Introduction In the highly regulated MedTech and pharmaceutical industries, even minor inconsistencies in technology can cascade into serious issues, jeopardizing product quality and patient health. To navigate these risks, organizations rely on GAMP 5 (Good Automated Manufacturing Practice), a globally recognized guideline created by the International Society for Pharmaceutical Engineering (ISPE). Historically, Computer System Validation […]

Introduction: Navigating ISPE GAMP 5 in the Pharmaceutical Industry MedTech and pharma companies face strict rules. Therefore, they must test their systems well. ISPE GAMP 5 helps with this exact task. It is a famous guide for GxP computerized systems. The guide keeps patients safe and ensures high product quality. This article explains the validation […]

Introduction In the MedTech and pharmaceutical industries, patient safety and product quality are not just goals; they are absolute mandates. To achieve these, organizations must navigate a complex regulatory landscape governed by GxP compliance. GxP acts as the foundational standard ensuring that every medical and pharmaceutical product is safe, effective, and reliable for consumer use. […]

Introduction to 21 CFR Part 11 Compliance Software In 2026, finding the right FDA 21 CFR Part 11 compliance software is critical for MedTech, pharmaceutical, and biotech companies aiming to transition from paper to digital environments securely. These digital tools are specifically designed to meet FDA requirements for creating, modifying, and maintaining electronic records and […]

Introduction: Navigating FDA 21 CFR Part 11 Compliance The life sciences industry currently experiences a rapid digital transformation. Companies continuously switch from traditional paper records to modern digital ecosystems. To execute this transition legally, organizations must prioritize FDA 21 CFR Part 11 compliance. Implementing an electronic signatures FDA framework requires strict technical and procedural controls. […]

Introduction: The Evolution of Medical Device QMS in 2026 The regulatory landscape for medical devices is undergoing a massive transformation. The most significant shift is the FDA’s Quality Management System Regulation (QMSR), which formally aligns the legacy 21 CFR Part 820 with ISO 13485 starting February 2, 2026. For MedTech companies, moving from fragmented, paper-based […]

Introduction to ISO 13485 and Medical Device Quality Management Systems The ISO 13485 implementation process is a critical milestone for any company developing health technologies. ISO 13485:2016 is the internationally recognized state-of-the-art standard that defines the requirements for a medical device Quality Management System. It provides a structured, repeatable framework to ensure that medical devices […]

Introduction As the medical device industry races forward in 2026, selecting the best medical device QMS is no longer just about passing an audit—it is about accelerating innovation and ensuring patient safety. With the FDA’s new Quality Management System Regulation (QMSR) formally aligning 21 CFR Part 820 with ISO 13485 standards taking effect this year, […]

Introduction to Digital Quality Infrastructure in MedTech The medical device industry is one of the most highly regulated sectors in the world. A single mistake in product design, manufacturing, or quality control can lead to devastating patient harm, costly product recalls, or FDA 483 warning letters. Historically, companies relied on fragmented, paper-based QMS systems to […]